​

Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?

OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary

Anavex Life Sciences is owned by 10.22% institutional investors, 3.12% insiders, and 86.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.45% of AVXL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.11% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences10.22%3.12%86.66%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.53M8.45%$26.79M
Blackrock6.39M7.75%$26.97M
Vanguard group5.03M5.90%$17.90M
State street3.29M3.85%$29.26M
Geode capital management2.02M2.27%$7.20M
Susquehanna group, llp1.13M1.36%$12.19M
Two sigma investments, lp1.04M1.21%$9.23M
Summit financial903.39K1.01%$3.22M
Goldman sachs group872.97K0.98%$3.11M
Northern trust773.01K0.91%$6.88M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pvg asset management216.29K1.64%$770.01K
Sheets smith investment management135.95K0.78%$1.21M
Allsquare wealth management52.38K0.27%$482.97K
Watts gwilliam26.00K0.07%$349.96K
October effect15.25K0.05%$46.82K
Summit financial903.39K0.05%$3.22M
180 wealth advisors119.47K0.04%$366.79K
Sheets smith wealth management117.81K0.04%$361.66K
Xtx topco81.70K0.04%$727.15K
Hayek kallen investment management12.10K0.03%$108.00K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp1.13M0.00%896.32K
Vanguard fiduciary trust647.17K0.00%647.17K
Goldman sachs group872.97K0.00%569.58K
Jane street group768.96K0.00%550.74K
Summit financial903.39K0.05%459.12K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Nwam---870.80K
Invesco56.70K0.00%-807.26K
Jupiter asset management---804.64K
Pier capital---415.91K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust647.17K0.00%647.17K$1.99M
Sheets smith investment management135.95K0.78%135.95K$1.21M
Xtx topco81.70K0.04%81.70K$727.15K
Lexaurum advisors67.45K0.03%67.45K$207.07K
Vanguard global advisers34.11K0.00%34.11K$104.71K

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Nelson, van denburg & campbell wealth management group-14.00
Stephens consulting-40.00
Eversource wealth advisors-55.00
Parkside financial bank & trust-60.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202563-68.34%8,715,170-73.43%100.69%29-67.42%21-56.25%
Sep 30, 202582-56.61%9,007,990-72.28%100.73%29-68.48%23-34.29%
Jun 30, 2025184-6.60%32,327,9853.05%372.78%89-11.00%35-23.91%
Mar 31, 20253-98.38%406,643-98.62%-0.04%2-98.04%--100.00%
Dec 31, 202418017.65%29,442,0845.60%343.11%9838.03%3822.58%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.88M3.11%-29.77K
Vanguard US Total Market Shares ETF2.53M2.98%-
Vanguard Total Stock Mkt Idx Inv2.73M2.95%-
iShares Russell 2000 ETF2.05M2.22%17.30K
SPDR® S&P Biotech ETF1.12M1.31%2.50K
Vanguard Institutional Extnd Mkt Idx Tr1.05M1.13%95.06K
Invesco Biotechnology & Genome ETF764.01K0.89%-2.40K
Fidelity Small Cap Index820.51K0.89%7.64K
iShares Russell 2000 Growth ETF723.43K0.78%-
iShares Biotechnology ETF654.55K0.71%-5.56K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

AVXL Ownership FAQ

Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 10.22%, followed by 3.12% insiders and 86.66% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 382.13%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7.53M shares, 8.45%), Blackrock (6.39M shares, 7.75%), and Vanguard group (5.03M shares, 5.90%). Together, they hold 22.10% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Pvg asset management is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 216.3K Anavex Life Sciences shares, valued at 770.01K$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Anavex Life Sciences shares, with 3.11% of its total shares outstanding invested in 2.88M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools